C5 inhibitors protect PNH clone from attack by blocking the complement activation pathway and significantly improve hemolytic anemia, reduce events of thrombosis, and alleviate damage of renal function.24, 25, 26, 27. Here, C5 is linked to paroxysmal nocturnal hemoglobinuria.